^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    AR-V7 negative

    almost2years
    Addition of samotolisib to #enzalutamide shows acceptable tolerability and clinical benefit in some patients with #mCRPC, esp. those who are androgen receptor splice variant 7 negative. https://t.co/Y8AR04vLSa @ChrisSweens1 @DavidMorrismd (@CCR_AACR)
    Clinical
    |
    AR (Androgen receptor)
    |
    AR splice variant 7 • AR-V7 negative
    |
    Xtandi (enzalutamide capsule) • samotolisib (LY3023414)